Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New Data On Teva’s Copaxone® And Laquinimod To Be Highlighted At ECTRIMS/ACTRIMS
The Street
Saturday, October 15, 2011 - 1:06pm
tags:
Teva Pharmaceuticals, Copaxone, laquinimod, multiple sclerosis
Takeda Eyes Nycomed Integration Before Another Deal
WSJ
Saturday, October 15, 2011 - 1:04pm
tags:
Nycomed, Takeda
Earnings Preview: Johnson & Johnson
Yahoo/Zacks
Saturday, October 15, 2011 - 12:57pm
tags:
JNJ
WuXi PharmaTech Shares Popped: What You Need to Know
Motley Fool
Saturday, October 15, 2011 - 12:55pm
tags:
WuXi PharmaTech, Abgent
Amarillo Biosciences Issues Corporate Update
Yahoo/PR NewsWire
Saturday, October 15, 2011 - 11:40am
tags:
Amarillo Biosciences, oral interferon, hepatitis C, hepatitis B
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Saturday, October 15, 2011 - 11:39am
tags:
Bristol-Myers Squibb, Dapagliflozin, BioSante, Bio-T-Gel, Regeneron, Eylea, Transcept, Intermezzo, Incyte, ruxolitinib, Antares, Anturol
Affymetrix's New Pan-African Array
Yahoo/Zacks
Saturday, October 15, 2011 - 11:36am
tags:
Affymetrix
Merck KGaA, Ono Pharma Collaborate
Yahoo/Zacks
Saturday, October 15, 2011 - 11:34am
tags:
Merck KGaA, Ono Pharmaceutical, ONO-4641, multiple sclerosis, Stimuvax, non-small cell lung cancer
AVI BioPharma gets bad news from Defense Dept., shares plummet
bizjournals
Saturday, October 15, 2011 - 11:28am
tags:
AVI BioPharma, defense contracts
Bullish MACD for Spectrum Pharma
Yahoo/Zacks
Saturday, October 15, 2011 - 11:26am
tags:
Spectrum Pharmaceuticals
Abbott Laboratories Earnings Preview
Motley Fool
Friday, October 14, 2011 - 1:08pm
tags:
earnings, Abbott Laboratories
8 Reasons To Buy Teva, The World's Largest Generic Drug Maker
Seeking Alpha
Friday, October 14, 2011 - 11:43am
tags:
Teva Pharmaceuticals, generics
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Friday, October 14, 2011 - 11:41am
tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Gilead, Human Genome Sciences, Incyte, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Theravance
Sinovac rises on Beijing flu vaccine contract
Yahoo/AP
Friday, October 14, 2011 - 11:38am
tags:
Beijing, Sinovac, vaccines
J&J Unit Cleared of Liability for Alleged Levaquin Injuries
Bloomberg
Friday, October 14, 2011 - 11:37am
tags:
JNJ, antibiotics, Levaquin, Ortho-McNeil-Janssen
Teva-Cephalon combination official, will have $20B in revenues
Bizjournals.com
Friday, October 14, 2011 - 11:27am
tags:
Teva Pharmaceuticals, M&A, Cephalon
Epizyme grabs $4M from partner GlaxoSmithKline
Bizjournals.com
Friday, October 14, 2011 - 11:24am
tags:
GSK, Epizyme, small molecule drugs
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bloomberg
Friday, October 14, 2011 - 11:23am
tags:
UK, Yervoy, Bristol-Myers Squibb, NICE, skin cancer
Option-based deals: How biotechs and big pharmas share R&D risks
Med City
Friday, October 14, 2011 - 11:18am
tags:
options, R&D, biotech, Big Pharma, Targacept, AstraZeneca
Ranbaxy recalls three drugs from UK market
Financial Express, India
Friday, October 14, 2011 - 11:17am
tags:
Ranbaxy, UK, recalls, Aciclovir, Oldaram, Tramadol, Fluconazole

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.